Medicine & Health
Updates every hour. Last Updated: 13-Jan-2026 05:11 ET (13-Jan-2026 10:11 GMT/UTC)
Bone metastases cultivate immature immune cells to resist immunotherapy
Ludwig Institute for Cancer ResearchPeer-Reviewed Publication
Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone metastases are often debilitating, even deadly. They are also notoriously resistant to all kinds of treatment, including immunotherapy.
- Journal
- Cancer Cell
- Funder
- Ludwig Institute for Cancer Research, Swim Across America, Breast Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, National Natural Science Foundation of China, National Key Research and Development Program of China, China Postdoctoral Science Foundation, Jiangsu Provincial Medical Key Discipline, Funding of the Major Program of Shenzhen Bay Laboratory, National Science and Technology Major Program, Fundamental Research Funds for the Central Universities, Jiangsu Provincial Science, Technology Plan Special Fund
Biomarkers reveal risk of cardiovascular disease in type 2 diabetes
Lund UniversityPeer-Reviewed Publication
An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is published in Cell Reports Medicine.
- Journal
- Cell Reports Medicine
Demographics, lifestyle, comorbidities, prediabetes, and mortality
JAMA NetworkPeer-Reviewed Publication
- Journal
- JAMA Network Open
Announcing Gordian Biotechnology as Tier 5 Sponsor of ARDD 2025
Aging Research and Drug DiscoveryMeeting Announcement
The University of Copenhagen is excited to announce Gordian Biotechnology as a Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
City of Hope Research Spotlight, July 2025
City of HopePeer-Reviewed Publication
City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.
Announcing NADMED as Tier 4 Sponsor of ARDD 2025
Aging Research and Drug DiscoveryMeeting Announcement